Leyden Labs helps people live freely by developing products that protect from known and new respiratory viruses.
Location: Netherlands
Total raised: $372.19M
Investors 2
| Date | Name | Website |
| - | F-Prime Ca... | fprimecapi... |
| 12.05.2021 | GV | gv.com |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 17.10.2025 | - | $35.08M | European I... |
| 04.06.2025 | - | $20M | European I... |
| 09.01.2025 | - | $70M | - |
| 25.01.2022 | Series B | $200M | GV |
| 29.03.2021 | Series A | $47.11M | - |
Mentions in press and media 20
| Date | Title | Description |
| 18.10.2025 | Leyden Labs Secures €30M for Groundbreaking Respiratory Nasal Spray | Leyden Laboratories, a Dutch biotechnology pioneer, recently secured a significant €30 million in equity funding. The European Innovation Council (EIC) Fund and Invest-NL spearheaded this investment. This crucial capital injection will prop... |
| 17.10.2025 | Leyden Labs: €30 Million Secured From EIC And Invest-NL | Dutch biotechnology company Leyden Laboratories B.V. has secured €30 million in new equity financing from the European Innovation Council (EIC) Fund and Invest-NL. The investment will accelerate the clinical development of the company’s pan... |
| 03.10.2025 | Leyden Laboratories Raises €30M in Equity Funding | Leyden Laboratories, a Leiden, the Netherlands-based biotechnology company developing nasal sprays, raised €30M in equity funding. The round was led by European Innovation Council (EIC) Fund and Invest-NL. The company intends to use the fun... |
| 08.08.2025 | Swiss VC investment in H1 reflects global trends | The market research and analytics firm CB Insights recently published its quarterly State of Venture report, analyzing startup ecosystem developments across the globe. A comparison with the H1 Update of the Swiss Venture Capital Report rev... |
| 04.06.2025 | Leyden Labs Receives $20M in Financing from EIB | Leyden Labs, a Leiden, the Netherlands-based clinical-stage biotechnology company, received $20M in financing. The round was led by the European Investment Bank (EIB). The company intends to use the funds to expand operations and its R&... |
| 22.01.2025 | CoV Biotechnology Takes Next Step to Become Leyden Labs Asia | Advancing its Mission to Combat Respiratory Infectious Diseases SINGAPORE, SINGPORE, SINGAPORE, January 22, 2025 /EINPresswire.com/ -- - CoV Biotechnology has been acquired by Leyden Labs and continues as Leyden Labs Asia on the global biot... |
| 09.01.2025 | Leyden Labs Raises $70M in Funding | Leyden Labs, a Leiden, the Netherlands-based provider of a mucosal protection platform, raised $70M in funding. The round was led by ClavystBio and Polaris Partners with participation from Qiming Venture Partners and continued backing from ... |
| 30.12.2022 | Dutch-based biotech and life sciences startups that raised funding in 2022 | The Netherlands is swiftly rising to the top as a hub for healthcare and life sciences innovation. More and more Dutch startups are engaged in a range of cutting-edge initiatives, such as the creation of digital health tools, the developmen... |
| 17.11.2022 | 10 Dutch startups that raised big funding rounds this year and are hiring now | The Netherlands is well-known for its large and successful startups, such as Adyen, Booking.com, and TomTom. And in recent years, there has been a surge in the number of smaller Dutch startups making a name for themselves. The Netherlands h... |
| 31.03.2022 | Meet the Amsterdam-based startups that raised funding in Q1 2022; 31 of them are hiring right now | Dutch startups and scale-ups saw significant growth in investments during the past year. According to a report from DSA (Dutch Startup Association), this trend is likely to continue in 2022, with foreign investors showing a lot of interest ... |
Show more